These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8844655)

  • 1. Enhancement of Streptococcus pneumoniae serotype 6B infection in mice after passive immunization with human serum.
    Aaberge IS; Hvalbye B; Løvik M
    Microb Pathog; 1996 Aug; 21(2):125-37. PubMed ID: 8844655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
    Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I
    J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal pneumonia and bacteremia model in mice for the analysis of protective antibodies.
    Saeland E; Vidarsson G; Jonsdottir I
    Microb Pathog; 2000 Aug; 29(2):81-91. PubMed ID: 10906263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae.
    Johnson SE; Rubin L; Romero-Steiner S; Dykes JK; Pais LB; Rizvi A; Ades E; Carlone GM
    J Infect Dis; 1999 Jul; 180(1):133-40. PubMed ID: 10353871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
    Villena J; Medina M; Racedo S; Alvarez S
    J Microbiol Immunol Infect; 2010 Feb; 43(1):1-10. PubMed ID: 20434117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection.
    Villena J; Medina M; Raya R; Alvarez S
    Can J Microbiol; 2008 Oct; 54(10):845-53. PubMed ID: 18923553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
    Sabirov A; Metzger DW
    Vaccine; 2006 Jul; 24(27-28):5584-92. PubMed ID: 16730398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic background of Streptococcus pneumoniae affects protection in mice immunized with PspA.
    He X; McDaniel LS
    FEMS Microbiol Lett; 2007 Apr; 269(2):189-95. PubMed ID: 17355599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
    Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y
    Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.
    Mohler J; Moine P; Azoulay-Dupuis E; Henin D; Fantin B
    Eur Cytokine Netw; 2007 Mar; 18(1):23-30. PubMed ID: 17400535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of occult pneumococcal bacteremia by an identical strain in an apparently healthy child.
    Matsubara K; Fukaya T; Ubukata K; Chen M; Nigami H; Harigaya H; Nozaki H; Tanaka T
    J Infect; 2007 Feb; 54(2):e87-90. PubMed ID: 16762416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants.
    Yu X; Gray B; Chang S; Ward JI; Edwards KM; Nahm MH
    J Infect Dis; 1999 Nov; 180(5):1569-76. PubMed ID: 10515817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
    Väkeväinen M; Eklund C; Eskola J; Käyhty H
    J Infect Dis; 2001 Sep; 184(6):789-93. PubMed ID: 11517443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
    Moore QC; Bosarge JR; Quin LR; McDaniel LS
    Vaccine; 2006 Jul; 24(29-30):5755-61. PubMed ID: 16759765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
    J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus.
    Dagan R; Givon-Lavi N; Fraser D; Lipsitch M; Siber GR; Kohberger R
    J Infect Dis; 2005 Aug; 192(3):367-76. PubMed ID: 15995949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.
    Briles DE; Hollingshead SK; King J; Swift A; Braun PA; Park MK; Ferguson LM; Nahm MH; Nabors GS
    J Infect Dis; 2000 Dec; 182(6):1694-701. PubMed ID: 11069242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcus pneumoniae pilus subunits protect mice against lethal challenge.
    Gianfaldoni C; Censini S; Hilleringmann M; Moschioni M; Facciotti C; Pansegrau W; Masignani V; Covacci A; Rappuoli R; Barocchi MA; Ruggiero P
    Infect Immun; 2007 Feb; 75(2):1059-62. PubMed ID: 17145945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice.
    Wu K; Yao R; Wang H; Pang D; Liu Y; Xu H; Zhang S; Zhang X; Yin Y
    Vaccine; 2014 Jul; 32(33):4179-88. PubMed ID: 24945468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.